» Articles » PMID: 19426212

CD28 and CTLA-4 Coreceptor Expression and Signal Transduction

Overview
Journal Immunol Rev
Date 2009 May 12
PMID 19426212
Citations 402
Authors
Affiliations
Soon will be listed here.
Abstract

T-cell activation is mediated by antigen-specific signals from the TCRzeta/CD3 and CD4-CD8-p56lck complexes in combination with additional co-signals provided by coreceptors such as CD28, inducible costimulator (ICOS), cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed death (PD-1), and others. CD28 and ICOS provide positive signals that promote and sustain T-cell responses, while CTLA-4 and PD-1 limit responses. The balance between stimulatory and inhibitory co-signals determines the ultimate nature of T-cell responses where response to foreign pathogen is achieved without excess inflammation and autoimmunity. In this review, we outline the current knowledge of the CD28 and CTLA-4 signaling mechanisms [involving phosphatidylinositol 3 kinase (PI3K), growth factor receptor-bound protein 2 (Grb2), Filamin A, protein kinase C theta (PKCtheta), and phosphatases] that control T-cell immunity. We also present recent findings on T-cell receptor-interacting molecule (TRIM) regulation of CTLA-4 surface expression, and a signaling pathway involving CTLA-4 activation of PI3K and protein kinase B (PKB)/AKT by which cell survival is ensured under conditions of anergy induction.

Citing Articles

Divide and Conquer-Targeted Therapy for Triple-Negative Breast Cancer.

Nedeljkovic M, Vuletic A, Mirjacic Martinovic K Int J Mol Sci. 2025; 26(4).

PMID: 40003864 PMC: 11855393. DOI: 10.3390/ijms26041396.


Tumor microenvironment as a novel therapeutic target for lymphoid leukemias.

Mousavi S, Nouri S, Sadeghipour A, Atashi A Ann Hematol. 2025; .

PMID: 39994019 DOI: 10.1007/s00277-025-06237-w.


Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer.

Liu X, Xi X, Xu S, Chu H, Hu P, Li D Front Immunol. 2024; 15:1507501.

PMID: 39726592 PMC: 11669709. DOI: 10.3389/fimmu.2024.1507501.


Exploring the Immunoresponse in Bladder Cancer Immunotherapy.

Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea L Cells. 2024; 13(23.

PMID: 39682686 PMC: 11640729. DOI: 10.3390/cells13231937.


CD8 + T-Cell-Related Genes: Deciphering Their Role in the Pancreatic Adenocarcinoma TME and Their Effect on Prognosis.

Zhang Y, Hou H, Zhang X, Lan H, Huo X, Duan X Dig Dis Sci. 2024; 70(1):262-284.

PMID: 39604668 DOI: 10.1007/s10620-024-08715-z.


References
1.
Villalba M, Coudronniere N, Deckert M, Teixeiro E, Mas P, Altman A . A novel functional interaction between Vav and PKCtheta is required for TCR-induced T cell activation. Immunity. 2000; 12(2):151-60. DOI: 10.1016/s1074-7613(00)80168-5. View

2.
Martin M, Schneider H, Azouz A, Rudd C . Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J Exp Med. 2001; 194(11):1675-81. PMC: 2193535. DOI: 10.1084/jem.194.11.1675. View

3.
Egen J, Allison J . Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity. 2002; 16(1):23-35. DOI: 10.1016/s1074-7613(01)00259-x. View

4.
Zha J, Harada H, Yang E, Jockel J, Korsmeyer S . Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 1996; 87(4):619-28. DOI: 10.1016/s0092-8674(00)81382-3. View

5.
Sherr C, Borzillo G, Kato J, Shurtleff S, Downing J, Roussel M . Regulation of cell growth and differentiation by the colony-stimulating factor 1 receptor. Semin Hematol. 1991; 28(2):143-51. View